CBT
BRKR icon

Capital Bank & Trust’s Bruker BRKR Stock Holding History

Capital Bank & Trust’s Portfolio BRKR Stock Details BRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-126
Closed -$6K – 723
2019
Q3 		$6K Buy
+126
New +$5.65K ﹤0.01% 585

Other funds holding BRKR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capital Bank & Trust's BRKR Position: Q4 2019 in Review

Capital Bank & Trust sold out of Bruker (BRKR) in Q4 2019, closing a stake of 126 shares — an estimated $6K sold.

Capital Bank & Trust first reported a position in BRKR in Q3 2019 and held it in 1 quarter. The position peaked at $6K in Q3 2019. 275 funds tracked by Wall St. Rank hold BRKR as of Q4 2019.

  • Capital Bank & Trust reported no remaining Bruker position as of Q4 2019 after selling out during the quarter.
  • Capital Bank & Trust sold 126 Bruker shares in Q4 2019, an estimated $6K.
  • Capital Bank & Trust first reported a position in Bruker in Q3 2019 and held it in 1 quarter.
  • Capital Bank & Trust's Bruker position peaked at $6K in Q3 2019.
  • 275 funds tracked by Wall St. Rank held Bruker as of Q4 2019.

Based on Capital Bank & Trust's 13F filing for Q4 2019, filed 18 Feb 2020.